LONG TERM WEIGHT MANAGEMENT TO PROMOTE REPRODUCTIVE HEALTH IN OVER WEIGHT/OBEASE WOMEN WITH POLYCYSTIC OVARIAN SYNDROME.   DR.PREMA.H.S,

Slides:



Advertisements
Similar presentations
Addressing Obesity and Exercise in Primary Care GSP 4 th Year Elective 2010.
Advertisements

L Exercise Training and Body Composition Training.
Assessment of Overweight and Obesity and the Need for Weight Loss Dr. David L. Gee FCSN/PE 446 Nutrition, Weight Control & Exercise.
10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
ASSESSMENT OF NUTRITIONAL STATUS Dr/Mervat salah Out comes By the end of this lecture the reader should be able to: To know the different methods for assessing.
CASE PRESENTATION (4)(6)(7)
Polycystic Ovarian Syndrome
Copyright © 2008 Delmar. All rights reserved. Chapter 21 Populations with Chronic Diseases.
PREGNANCY RELATED HYPERTENSION By Dr. Ali Abd El-Monsif Thabet.
Infertility and PCOS Erinn Myers, M4 Department of Obstetrics and Gynecology University of Tennessee Health Science Center January 28, 2007.
Valerie Robinson, DO. Polycystic Ovarian Syndrome (PCOS) is a disorder that causes menstrual and ovulation irregularities, androgen excess, and infertility.
Andrea Myers KNH 411.  Gracie Moore  34  Female  5’5”  180lbs  Graduate Student  Graduate teaching assistant  Married  One adopted child, infant.
Polycystic ovarian syndrome PCO
+ Differential Effects of Walnuts vs Almonds on Improving Metabolic and Endocrine Parameters in PCOS European Journal of Clinical Nutrition 2011; 65:
Emily Bartlett Katrina Bush
PCOS Polycystic Ovary Syndrome
TEMPLATE DESIGN © Laparoscopic Ovarian Drilling For Polycystic Ovary Syndrome(PCOS) – Are We Wasting Women’s Time? Chima.
Anti-Mullerian Hormone in the pathophysiology of PCOS Roy Homburg Homerton University Hospital, London & Barzilai Medical Centre, Ashkelon, Israel.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
By: patra cain, SN Smh/ud
Insulin sensitizing agents use in pregnancy and as therapy in PCOS
INFERTILITY ASSOCIATED WITH PCOS Dr. Norlia Bahauddin Hospital Kajang.
Body Mass Index (BMI) This is the most commonly used index of over or underweight Body Mass Index = body weight ( Height) squared ClassificationBMI.
Understanding Body Composition
Ovaries and the Fertility Cycle
Mr. Ovalle.  Read the “Alligator River” passage  Rate each character from least offensive (1) to most offensive (5)  Explain why you chose your number.
Ovaries By Carla Fera & Gina Rossetti. Physical Description Ovaries have an oval shape. It is located at the lateral wall of the pelvis in a region called.
Infertility New Issues. Yunus Tayob Clinical Lead in Reproductive Medicine and Reproductive Endoscopic Surgery.
Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA.
Adult Medical-Surgical Nursing Reproductive Health Module: Ovarian Cyst Polycystic Ovary Syndrome.
HDR Women’s Health 11 th April 2012 By Dr Mahya Mirfattahi GP ST3 POLYCYSTIC OVARY SYNDROME A SUMMARY OF RCOG GREEN-TOP GUIDELINE.
Polycystic Ovary Syndrome
Nutrition and Dietetics in the Normal Patient
الجامعة السورية الخاصة كلية الطب البشري قسم طب المجتمع
Sport Books Publisher1 Weight Management: Finding a Healthy Balance Chapter 11.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
Chapter 15 Adolescent Nutrition: Conditions and Interventions
Coagulation / Fibrinolytic Factors in PCOS. The Alternative Hypothesis : Conversely, PCOS women may be protected from later life onset of CHD by the altered.
DR.ABHISHEK SINGH PARIHAR M.S (Obs & Gyne) ; FELLOW REPRODUCTIVE MEDICINE CONSULTANT : LIFECARE IVF CENTRE, NEW DELHI ABALONE CLINIC, NOIDA ETERNA IVF.
The Effects of Inositol on Women with Polycystic Ovary Syndrome(PCOS)
Pathogenesis (etiology?) Hypersecretion of adrenal androgens? Hypersecretion of ovarian androgens? A genetic disorder with an autosomal dominant mode.
Investigating infertile couple
Body Image and Disordered Eating. What is Body Image? What are causes of Eating Disorders? What are eating disorders? Treatment Prevention.
Prevention Of Diabetes. Type 2 Diabetes: Hyperglycemia Insulin Resistance Relative Impairment of Insulin Secretion Pathogenesis: Poorly Understood Genetic.
Polycystic ovarian syndrome Can lifestyle modifications help??
ACSM, The female athlete triad (Triad) refers to the interrelationships among energy availability, menstrual function, and bone mineral density,
Please Be Sure You Have An Audience-Response Device (Clicker)
PCOS & EXERCISE Bob Tygenhof, MA, CPT Director, Center for Active Lifestyle Medicine Integrative Medical Group of Irvine.
L/O/G/O Efficacy of GnRHa plus Yasmin or Mirena in the treatment of polycystic ovarian syndrome with atypical hyperplasia in patients with adenomyosis.
CHAPTER 7: Obesity in Women. Introduction 68% of U.S. population is overweight or obese. Resulting medical and psychosocial difficulties can be debilitating.
Body Weight and Body Composition
Ovarian Cysts Kasey Durham. What are Ovarian Cysts? The Mayo Clinic defines ovarian cysts as fluid filled sacs or pockets located within or on the ovary.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Peter Valenzuela, MD, MBA Texas Tech University Health Sciences Center at the Permian Basin.
Polycystic Ovarian Syndrome Lindsay White. Polycystic Ovarian Syndrome (PCOS) is the most common cause of female infertility.
DR.GARIMA TYAGI Senior Consultant Obstetrician,Gynaecologist Infertility consultant & Laparoscopic Surgeon SHREE NARAYAN HOSPITAL, INDIRAPURAM,GHAZIABAD.
How Does Body Maintain Normal Blood Sugar? a Insulin Resistance and Its Consequences Sidika E. Karakas, M.D Professor and Chief Division of Endocrinology,
Need For Action. Blood glucose levels are higher than normal but not yet diabetes ** 1 in 3 American adults (79 million) have prediabetes Occurs before.
Coagulation/Fibrinolytic Factors in PCOS
Polycystic ovarian syndrome Obesity and Insulin resistance
Polycystic Ovarian Syndrome (PCOS) Specialized Package For Women.
UOG Journal Club: December 2016
Nutritional assessment in hospitalized patients
Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women.
Presentation transcript:

  LONG TERM WEIGHT MANAGEMENT TO PROMOTE REPRODUCTIVE HEALTH IN OVER WEIGHT/OBEASE WOMEN WITH POLYCYSTIC OVARIAN SYNDROME.   DR.PREMA.H.S,

INTRODUCTION Obesity in women induces a range of co-morbidities like irregular menstrual cycle, anovulatory infertility, hirsutism, acne, hyperinsulinemia, dyslipidemia and hyperandrogenism. These are said to constitute the polycystic ovarian syndrome

PCOS is an excellent example of a syndrome for which early recognition and intervention of - Weight control Diet modification Life style changes Prevent or delay the development of further problems. Hence long-term holistic interest is needed to correct the reproductive health of the affected women.

Objectives To evaluate the somatic status of the obese women with PCOS. To evaluate the relationship between obesity and PCOS. Planning and evaluating the wt. management in reversal of the condition  

SELECTION OF SUBJECTS     subjects having a BMI greater than 25 with the clinical manifestation of menstrual irregularities, were selected.     While selecting the subjects it was found out that some of them are with or with out hirsutism, acne, dyslipidemia, hyprerinsulinemia with PCOS.

DEVELOPMENT OF TOOLS Personal data Anthropometrical measurements Co-morbidites associated with obese PCOS Dietary pattern,food preferences and food frequency Health practices Physical activities Behavioral pattern

METHODOLOGY Assessment of somatic state of obesity through anthropometrics- Ht. Wt. MUAC. SFT. W&H Assessment of body composition by bio-electrical impendence Bio-chemical assessment of serum Hb, RBS, PPBS,serum insulin & lipid profile. Assessment of presence of ovarian cysts by ultra sound scanning (pelvic or TVS).

Initially dietary counseling was given to all the subjects in the presence of their family members. Dietary modification was aimed to provide hypo caloric diet with 12 to 15 % of fat. Assessment of effective wt. reduction through anthropometrics i.e. wt, skin fold thick ness, MAC, W&H Measurements was done periodically. Assessment of presence of ovarian cysts and size of the ovaries were checked by ultra sound scanning at a specific period.

RESULTS A loss of an average of 10 kg over a period of 5 months Reduced ovarian size and the disappearance of or reduction of cysts in both the ovaries or in a single ovary. Subjects showing on an average a reduction of 10kg body wt., were found to have regular menstrual cycles. While the subjects losing, on an average, 2 kg body wt. still continue to show menstrual irregularities.

As assessed by bio-electrical impedance body compositions suggest reduced fat % with elevated TBW & FFM. The improvement of WHR. Three of the married subjects conceived spontaneously without any medical intervention These findings suggest that the wt. reduction through dietary modification have a role in the improvement of reproductive health of obese women with PCOS.

Normal uterus with bilateral polycystic ovaries. Right ovary measured 2.5x1.6x3.1 cm(volume 6.2 cc) Left ovary measured 3.1x1.7x2.9 cm(volume 7.6 cc)

Findings are suggestive of a very early intra-uterine gestation of about 5+ weeks. Both ovaries appeared normal and Corpus-luteum was seen in the right ovary. 3.1x1.2x2.0 (volume 3.7 cc) 3.0x2.1x3.6 cm (Corpus-luteum – 1.8x1.5x1.8 cm)

Bilateral polycystic ovaries with slight decrease in size since last scan done. Before wt. loss 3.7x2.2 cm After wt. loss 3.4x1.7 cm Before wt. loss 3.8x2.0 cm After wt. loss 3.1x1.7 cm

Size of the ovary before and after the dietary treatment Right ovary (cm) Left ovary Total loss of volume (cm) Before After After treatment 4.0× 2.1 2.0 ×1.9 4.0× 2.3 3.5× 1.8 7.5 3.6 ×2.0 2.5× 1.7 3.0 ×2.2 2.6 ×1.6 5.39 4.8 ×1.1 2.6× 1.0 4.8× 1.1 1.8× 0.6 6.88 4.4 ×2.0× 2.7 3.4× 1.2× 1.5 3.4 ×1.9 ×2.1 1.8× 0.2× 2.0 6.84 3.0× 2.4 1.1× 1.6 2.6× 2.2 1.6×0.5 6.72 4.3×2.4 1.9× 0.5 5.0×2.8 2.9×1.3 19.6

Average wt. Loss of the respondents.

Average reduction of WHR of the respondents.

Average reduction of fat % of the respondents

CONCLUSION Obesity appears to be a major cause for the development/progression of PCOS. Hence effective wt. Management among PCOS cases is imperative to restore the normal menstrual cycles